<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://www.crsguidelines.org/index.php?action=history&amp;feed=atom&amp;title=ROCURONIUM_%28ZEMURON%29</id>
	<title>ROCURONIUM (ZEMURON) - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.crsguidelines.org/index.php?action=history&amp;feed=atom&amp;title=ROCURONIUM_%28ZEMURON%29"/>
	<link rel="alternate" type="text/html" href="https://www.crsguidelines.org/index.php?title=ROCURONIUM_(ZEMURON)&amp;action=history"/>
	<updated>2026-04-20T16:50:55Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.37.2</generator>
	<entry>
		<id>https://www.crsguidelines.org/index.php?title=ROCURONIUM_(ZEMURON)&amp;diff=122&amp;oldid=prev</id>
		<title>Cgabryszek: Created page with &quot;&#039;&#039;&#039;Class&#039;&#039;&#039;  Skeletal muscle relaxant, neuromuscular blocking agent  &#039;&#039;&#039;Pharmacology and Actions&#039;&#039;&#039;  # Non-depolarizing neuromuscular blocking agent with intermediate to rapid onset # Acts by competitive inhibition of cholinergic receptors at the motor end-plate # Higher doses produce a longer duration of action  &#039;&#039;&#039;Indications for Use:&#039;&#039;&#039;  # Facilitate endotracheal intubation # Provide skeletal muscle relaxation for mechanical ventilation  &#039;&#039;&#039;Contraindications&#039;&#039;&#039;  # Kno...&quot;</title>
		<link rel="alternate" type="text/html" href="https://www.crsguidelines.org/index.php?title=ROCURONIUM_(ZEMURON)&amp;diff=122&amp;oldid=prev"/>
		<updated>2022-04-04T03:54:58Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;&amp;#039;&amp;#039;&amp;#039;Class&amp;#039;&amp;#039;&amp;#039;  Skeletal muscle relaxant, neuromuscular blocking agent  &amp;#039;&amp;#039;&amp;#039;Pharmacology and Actions&amp;#039;&amp;#039;&amp;#039;  # Non-depolarizing neuromuscular blocking agent with intermediate to rapid onset # Acts by competitive inhibition of cholinergic receptors at the motor end-plate # Higher doses produce a longer duration of action  &amp;#039;&amp;#039;&amp;#039;Indications for Use:&amp;#039;&amp;#039;&amp;#039;  # Facilitate endotracheal intubation # Provide skeletal muscle relaxation for mechanical ventilation  &amp;#039;&amp;#039;&amp;#039;Contraindications&amp;#039;&amp;#039;&amp;#039;  # Kno...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Class&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
Skeletal muscle relaxant, neuromuscular blocking agent&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Pharmacology and Actions&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Non-depolarizing neuromuscular blocking agent with intermediate to rapid onset&lt;br /&gt;
# Acts by competitive inhibition of cholinergic receptors at the motor end-plate&lt;br /&gt;
# Higher doses produce a longer duration of action&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Indications for Use:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Facilitate endotracheal intubation&lt;br /&gt;
# Provide skeletal muscle relaxation for mechanical ventilation&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Contraindications&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Known hypersensitivity to rocuronium&lt;br /&gt;
# Myasthenia gravis&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Precautions&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Severe liver disease.&lt;br /&gt;
# Vancomycin and tetracycline antibiotics prolong the effects.&lt;br /&gt;
# Tegretol and Dilantin decrease the effects and duration.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Side Effects:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Cardiovascular: arrhythmias, tachycardia&lt;br /&gt;
# Respiratory:  bronchospasm, hiccups&lt;br /&gt;
# Dermatologic:  rash, itching, injection site edema&lt;br /&gt;
# Gastrointestinal:  nausea, vomiting&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Administration:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Rapid Sequence Intubation Dose: 1 mg/kg IV/IO, may repeat one time after 2 minutes if   inadequate response is obtained.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Side Effects and Special Notes:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Duration of effect is slightly increased in patients &amp;gt; 65 year&lt;br /&gt;
# Compatible with all IV solutions&lt;/div&gt;</summary>
		<author><name>Cgabryszek</name></author>
	</entry>
</feed>